Company Overview and News

Strong response expected for 3,000 flats set to launch in Tai Po

2018-05-23 scmp
K Wah Group will soon announce details of its 1,122-unit Solaria development in Pak Shek Kok, while Sun Hung Kai Properties and Billion Development are also gearing up to launch their respective projects

The Hong Kong Housing 'Bubble' And The Foreign Exchange Rate

2018-05-22 seekingalpha
Housing prices in Hong Kong have been rising for more than a decade and recent hikes are mainly driven by Mainland developers in the primary market.

Hong Kong developers raise prices of flats by up to 70 per cent as record Kai Tak land sale boosts confidence

2018-05-22 scmp
Analysts say the surge has been fuelled by a land auction at the site of the city’s former airport which fetched HK$25.16 billion, a record price for a residential plot

Chinese stocks rise to 5-week high as Mnuchin says trade war ‘on hold’

2018-05-21 scmp
China agrees to buy more US agricultural and energy products to help narrow what has become a record bilateral trade deficit, the White House said in a joint statement with China following two days of negotiations

Hong Kong’s millennials join red-hot property party, snap up 50pc of units launched over weekend

2018-05-20 scmp
About half the 94 units at Wings At Sea released by Sun Hung Kai Properties over the weekend have been snapped by those in the 22-37 age group

Group led by Hong Kong conglomerate New World Development wins Singapore plot for US$306.76 million

2018-05-17 scmp
Hong Kong conglomerate New World Development is part of a consortium that has won the tender for a luxury residential site close to Orchard Road, Singapore’s famous shopping and entertainment strip, securing the plot for S$2,377 per square foot, a record for all government residential sites in the city.

Hong Kong’s record US$3.2bil land sale shows rate fear is benign

Super high-end: The Kai Tak area in Kowloon has become one of Hong Kong’s hottest property markets, attracting a flock of investors in recent years. — Reuters

Sun Hung Kai pays HK$25.1 billion for Hong Kong’s costliest residential land at Kai Tak

2018-05-15 scmp
One of the city’s largest land owners won the 14th government tender by paying a record HK$25.1 billion for a plot with gross floor area of 1.42 million sq ft

What may end HK property boom? Here are the triggers

2018-05-14 bworldonline
HONG KONG property companies such as Sun Hung Kai Properties Ltd. and CK Asset Holdings Ltd. are bracing for the first increase in the city’s prime rate in more than a decade. A higher prime rate, which sets the upper limits on mortgages, could damp surging housing prices in the world’s least-affordable real estate market.

Buyers snap up all 188 units at new Tuen Mun development, raising HK$1.1 billion for Hong Kong’s Sun Hung Kai Properties

2018-05-12 scmp
City’s first new project launch since March drew 5,200 prospective buyer registrations, making it more than 26 times oversubscribed

Hong Kong developers speed up sale of empty flats as plans for vacancy tax gathers steam

2018-05-12 scmp
Experts say the Hong Kong government will have to commit a lot of resources and will have to close every possible loophole for the tax to be effective

Kai Tak plot could fetch US$3.25 billion, smashing records for Hong Kong land sales

2018-05-11 scmp
Developers are forming consortiums to spread the financial risk of bidding for a residential site that could fetch an estimated US$3.25 billion

Politics a barrier to plans to help alleviate Hong Kong’s housing shortage, tycoon Victor Li says   

2018-05-09 scmp
Hong Kong tycoon Victor Li Tzar-kuoi sees political considerations as a major barrier to a government plan for joint public and private development of agricultural land for housing, casting doubt on whether the model could help boost home affordability in the city.

Sino Land, CSI join forces to win Yau Tong land site, adding even more appeal to former Kowloon industrial area

2018-05-08 scmp
Winning bid not disclosed, but the land premium paid on the site was confirmed at HK$1.515 billion (US$193 million)

Sino Land, CSI join forces to win Yau Tong land site, adding even more appeal to former Kowloon industrial area

2018-05-08 scmp
Winning bid not disclosed, but the land premium paid on the site was confirmed at HK$1.515 billion (US$193 million)

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...